Why Practice Owners Choose Us

We collaborate with practices focused on outstanding outcomes and disciplined growth. If you value measurable results, streamlined operations, and consistent patient education, we’ll be a great fit.

Schedule A Discovery Call

AOD-9604

AOD 10mg Peptide Available In:
5mg
10mg
Click Here For Provider Pricing

AOD-9604 (Anti-Obesity Drug-9604) is a synthetic peptide fragment of human growth hormone (HGH), consisting of amino acids 176–191. Unlike full HGH, AOD-9604 does not stimulate IGF-1 production or general growth pathways. Instead, it has been studied primarily for its potential role in regulating fat metabolism. It remains experimental and is not FDA-approved as a therapy.

How It Is Used in Research Settings

  • Explored for stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) in adipose tissue models.
  • Studied in obesity and metabolic syndrome research for weight management support.
  • Examined in animal studies for potential effects on cartilage repair and joint health.
  • Investigated as a safer alternative to HGH without impacting blood sugar or IGF-1 pathways.

Proposed Uses (Research Areas)

  • Obesity and fat metabolism studies.
  • Metabolic syndrome and insulin resistance models.
  • Joint repair and cartilage protection (preclinical data).
  • Aging and weight management research.

How It Is Dosed in Research Settings

  • Injectable: Typically studied at 300 mcg to 600 mcg subcutaneously once daily.
  • Oral formulations: Investigated in capsule form, though bioavailability and efficacy are less well established.
  • Cycle length: Common research protocols range from 12–24 weeks for weight and metabolic outcomes.
  • Handling: Supplied as a lyophilized powder; reconstituted with bacteriostatic water and stored refrigerated.

Important Considerations

  • Regulatory status: AOD-9604 is not FDA-approved; all applications remain experimental.
  • Evidence base: Most data comes from preclinical studies and small clinical trials; larger studies are needed.
  • Safety: Reported as well tolerated in short studies, with low risk of hypoglycemia compared to HGH. Long-term safety is unknown.

Disclaimer

This material is provided for educational purposes only and summarizes published research on AOD-9604. It is not medical advice. AOD-9604 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.

This peptide is for research use only.

Ready to Transform Your Practice?
Schedule your complimentary Discovery Call today and take the first step toward integrating advanced therapies into your practice.
Schedule A Discovery Call